Chongqing University Cancer Hospital — Chongqing, Chongqing Municipality

Public research footprint of Chongqing University Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

243

Registered studies

167

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Diffuse Large B-Cell Lymphoma (DLBCL) · Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT07222267 — An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic… (Recruiting)
NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Chongqing University Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.